Published in
Springer, PharmacoEconomics, 9(39), p. 1099-1099, 2021
DOI: 10.1007/s40273-021-01057-y
Links
Tools
Correction to: Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study
Journal article published in 2021 by
Becky Pennington 
,
Abualbishr Alshreef ,
Laura Flight ,
Andrew Metry ,
Edith Poku,
Philip Hykin,
Sobha Sivaprasad,
A. Toby Prevost ,
Joana C. Vasconcelos,
Caroline Murphy,
Joanna Kelly,
Yit Yang,
Andrew Lotery ,
Michael Williams,
John Brazier
,
Abualbishr Alshreef ,
Laura Flight ,
Andrew Metry ,
Edith Poku,
Philip Hykin,
Sobha Sivaprasad,
A. Toby Prevost ,
Joana C. Vasconcelos,
Caroline Murphy,
Joanna Kelly,
Yit Yang,
Andrew Lotery ,
Michael Williams,
John Brazier
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 